UBS Group’s CyrusOne Inc Common Stock CONE Stock Holding History

UBS Group’s Portfolio CONE Stock Details CONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,300	Closed	-$406K	–	8059
2016 Q2	$406K	Sell	7,300 -3,100	-30%	-$149K	﹤0.01%	4045
2016 Q1	$475K	Sell	10,400 -3,200	-24%	-$122K	﹤0.01%	3816
2015 Q4	$509K	Sell	13,600 -5,900	-30%	-$209K	﹤0.01%	3938
2015 Q3	$637K	Buy	+19,500	New	+$620K	﹤0.01%	3707
2015 Q1	–	Sell	-54,200	Closed	-$1.49M	–	9588
2014 Q4	$1.49M	Buy	+54,200	New	+$1.42M	﹤0.01%	3194

Other funds holding CONE

JCM

Jag Capital Management St Louis, Missouri $1.07B AUM 60.59% 1-Year Est. Return

Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

UBS Group's CONE Position: Q1 2022 in Review

UBS Group sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 929,188 shares — an estimated $83.4M sold.

UBS Group first reported a position in CONE in Q4 2014 and held it in 29 quarters. The position peaked at $83.4M in Q4 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

UBS Group reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
UBS Group sold 929,188 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $83.4M.
UBS Group first reported a position in CyrusOne Inc Common Stock in Q4 2014 and held it in 29 quarters.
UBS Group's CyrusOne Inc Common Stock position peaked at $83.4M in Q4 2021.
3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.